Phase 2 Trial Of Induction Chemotherapy Regimen (GEMPOX) Followed By A Single Cycle Of High Dose Chemotherapy (HDC) And Autologous Hematopoietic Stem Cell Rescue (AUHSCR) For Patients With Recurrent Or Progressive Intracranial Germ Cell Tumors

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Malignant Neoplasm Of Brain
  • Age: Between 0 years - 100 years
  • Gender: Male or Female
  • Other Inclusion Criteria:

    1. Patients must have a diagnosis with intracranial germ cell tumor including pure germinoma, mixed malignant germ cell tumor.

    2. Patients who have not received previously a high dose chemotherapy regimen and autologous transplant.

     


You may not be eligible for this study if the following are true:

  • 1.  Patients with central nervous system germ cell tumors who are newly diagnosed

     

    2.  Patients with the diagnosis of mature or immature teratoma in the absence of tumor marker elevations are excluded from the study

     

    3.  Patients who have received gemcitabine, oxaliplatin, and/or paclitaxel are excluded from this study




If you are registered as a volunteer, please log in to contact the study team/express interest in this study.